Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN)

Clinical trial NCT01788332 · UNKNOWN

Trial details

NCT number: NCT01788332
Sponsor: Lisette Nixon
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2014-01-01
Primary completion: 2018-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.